NEMLUVIO 30 mg, powder and solvent for solution for injection in a pre-filled pen cartridge, 0.49 ml
Active ingredients: NÉMOLIZUMAB
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectioncartridge, 0.49 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEMLUVIO 30 mg, poudre et solvant pour solution injectable en stylo prérempli
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche à double chambre en verre en stylo pré-rempli de 30 mg de poudre et de 0,49 mL de solvant
- Marketing authorisation holder
- GALDERMA INTERNATIONAL
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60661547CIP73031530CIP133400930315309Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NÉMOLIZUMABpoudre | 30 mg · une dose de 0,49 mL après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.